Mesoblast Limited
MEOBF
$1.90
$0.2515.15%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 34.45M | 34.45M | 25.67M | 25.67M | 7.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.45M | 34.45M | 25.67M | 25.67M | 7.02M |
| Cost of Revenue | -14.87M | -14.87M | 26.88M | 26.88M | 6.27M |
| Gross Profit | 49.32M | 49.32M | -1.21M | -1.21M | 755.00K |
| SG&A Expenses | 14.40M | 14.40M | 14.27M | 14.27M | 10.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.31M | 1.31M | -1.32M | -1.32M | 176.00K |
| Total Operating Expenses | 45.92M | 45.92M | 39.83M | 39.83M | 28.25M |
| Operating Income | -11.47M | -11.47M | -14.16M | -14.16M | -21.23M |
| Income Before Tax | -8.59M | -8.59M | -19.86M | -19.86M | -27.05M |
| Income Tax Expenses | 84.00K | 84.00K | 222.50K | 222.50K | 59.00K |
| Earnings from Continuing Operations | -8.67M | -8.67M | -20.08M | -20.08M | -27.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.67M | -8.67M | -20.08M | -20.08M | -27.10M |
| EBIT | -11.47M | -11.47M | -14.16M | -14.16M | -21.23M |
| EBITDA | -9.97M | -9.97M | -12.53M | -12.53M | -19.64M |
| EPS Basic | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.30B | 1.30B | 1.29B | 1.29B | 1.27B |
| Average Diluted Shares Outstanding | 1.30B | 1.30B | 1.29B | 1.29B | 1.27B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |